100 related articles for article (PubMed ID: 11501173)
1. Polymorphism of CYP450 and cancer susceptibility.
Han XM; Zhou HH
Acta Pharmacol Sin; 2000 Aug; 21(8):673-9. PubMed ID: 11501173
[TBL] [Abstract][Full Text] [Related]
2. [Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility].
Gu YF; Zhang ZD; Zhang SC; Zheng SH; Jia HY; Gu SX
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3064-8. PubMed ID: 18261353
[TBL] [Abstract][Full Text] [Related]
3. [Study of the molecular mechanism of human cytochrome P450 and genetic polymorphism of drug oxidative metabolizing enzyme].
Zhao L; Lou YQ
Sheng Li Ke Xue Jin Zhan; 1997 Jan; 28(1):35-40. PubMed ID: 10921075
[TBL] [Abstract][Full Text] [Related]
4. Interaction between cytochrome P450 1A2 genetic polymorphism and cigarette smoking on the risk of hepatocellular carcinoma in a Japanese population.
Imaizumi T; Higaki Y; Hara M; Sakamoto T; Horita M; Mizuta T; Eguchi Y; Yasutake T; Ozaki I; Yamamoto K; Onohara S; Kawazoe S; Shigematsu H; Koizumi S; Kudo S; Tanaka K
Carcinogenesis; 2009 Oct; 30(10):1729-34. PubMed ID: 19643819
[TBL] [Abstract][Full Text] [Related]
5. [Study on polymorphisms in metabolic enzyme genes, DNA repair genes and individual susceptibility to hepatocellular carcinoma].
Ye XP; Peng T; Li LQ
Wei Sheng Yan Jiu; 2006 Nov; 35(6):805-7. PubMed ID: 17290773
[TBL] [Abstract][Full Text] [Related]
6. Association of CYP1A2 genetic polymorphisms with hepatocellular carcinoma susceptibility: a case-control study in a high-risk region of China.
Chen X; Wang H; Xie W; Liang R; Wei Z; Zhi L; Zhang X; Hao B; Zhong S; Zhou G; Zhang L; Gao X; Zhu Y; He F
Pharmacogenet Genomics; 2006 Mar; 16(3):219-27. PubMed ID: 16495781
[TBL] [Abstract][Full Text] [Related]
7. CYP450 polymorphisms predict clinic outcomes to vinorelbine-based chemotherapy in patients with non-small-cell lung cancer.
Pan JH; Han JX; Wu JM; Sheng LJ; Huang HN
Acta Oncol; 2007; 46(3):361-6. PubMed ID: 17450472
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms in cytochrome P450 genes are associated with an increased risk of squamous cell carcinoma of the larynx and hypopharynx in a Chinese population.
Tai J; Yang M; Ni X; Yu D; Fang J; Tan W; Huang Z; Wu C; Chen X; Wang G; Zhou W; Chen X; Zhang W; Ma L; Lin D; Han D
Cancer Genet Cytogenet; 2010 Jan; 196(1):76-82. PubMed ID: 19963139
[TBL] [Abstract][Full Text] [Related]
9. CYP450 polymorphisms as risk factors for early-onset lung cancer: gender-specific differences.
Timofeeva MN; Kropp S; Sauter W; Beckmann L; Rosenberger A; Illig T; Jäger B; Mittelstrass K; Dienemann H; ; Bartsch H; Bickeböller H; Chang-Claude JC; Risch A; Wichmann HE
Carcinogenesis; 2009 Jul; 30(7):1161-9. PubMed ID: 19414505
[TBL] [Abstract][Full Text] [Related]
10. Do single nucleotide polymorphisms in xenobiotic metabolizing genes determine breast cancer susceptibility and treatment outcomes?
Singh V; Parmar D; Singh MP
Cancer Invest; 2008 Oct; 26(8):769-83. PubMed ID: 18798070
[TBL] [Abstract][Full Text] [Related]
11. Polymorphism of glutathione S-transferase omega gene and risk of cancer.
Marahatta SB; Punyarit P; Bhudisawasdi V; Paupairoj A; Wongkham S; Petmitr S
Cancer Lett; 2006 May; 236(2):276-81. PubMed ID: 15992993
[TBL] [Abstract][Full Text] [Related]
12. Chapter 21. Additional polymorphisms and cancer.
Stubbins MJ; Wolf CR
IARC Sci Publ; 1999; (148):271-302. PubMed ID: 10493263
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers.
Zienolddiny S; Campa D; Lind H; Ryberg D; Skaug V; Stangeland LB; Canzian F; Haugen A
Carcinogenesis; 2008 Jun; 29(6):1164-9. PubMed ID: 18258609
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of microsomal epoxide hydrolase gene and severity of HCV-related liver disease.
Sonzogni L; Silvestri L; De Silvestri A; Gritti C; Foti L; Zavaglia C; Bottelli R; Mondelli MU; Civardi E; Silini EM
Hepatology; 2002 Jul; 36(1):195-201. PubMed ID: 12085365
[TBL] [Abstract][Full Text] [Related]
15. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
Zhou SF; Liu JP; Chowbay B
Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
[TBL] [Abstract][Full Text] [Related]
16. Polymorphic Variants of Cytochrome P450: Relevance to Cancer and Other Diseases.
Daly AK
Adv Pharmacol; 2015; 74():85-111. PubMed ID: 26233904
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphism of metabolic enzymes P450 (CYP) as a susceptibility factor for drug response, toxicity, and cancer risk.
Bozina N; Bradamante V; Lovrić M
Arh Hig Rada Toksikol; 2009 Jun; 60(2):217-42. PubMed ID: 19581216
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India.
Srivastava DS; Mandhani A; Mittal RD
Arch Toxicol; 2008 Sep; 82(9):633-9. PubMed ID: 18200441
[TBL] [Abstract][Full Text] [Related]
19. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
20. ABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatment.
Crettol S; Déglon JJ; Besson J; Croquette-Krokar M; Hämmig R; Gothuey I; Monnat M; Eap CB
Clin Pharmacol Ther; 2006 Dec; 80(6):668-81. PubMed ID: 17178267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
